@MarketBeatMedia
YouTube
Avg. Quality
70
Success Rate
34.22
Analysis
561
Correct
192
Fail
244
Pending
121
Ineffective
0
Total Quality
Score
If You Had Traded on This Analysis…
Pending
VXRT
Long Entry
0.7198
2026-02-26
03:00 UTC
Target
2.0000
Fail
0.5000
Risk/Reward
1 : 6
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
Live PnL
—
P/L: —
Turn Signals into Profit
Join Tahlil Plus Pro to unlock full performance history, live alerts, and AI-backed risk tools.
Start Free
The video discusses Vaxart (VXRT), a biotech penny stock trading around $0.68. A single analyst has given it a price target of $2.00, indicating a potential 195% upside. The rationale behind this target is the company's pipeline of oral vaccines, with some drugs in clinical stages (Stage 2 and Stage 3). The successful FDA approval and market entry of these oral vaccines could significantly boost the company's valuation, as this is an under-covered area of the market.